Black Rock Inc. Centessa Pharmaceuticals PLC Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Black Rock Inc. holds 464,622 shares of CNTA stock, worth $7.97 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

464,622

Previous 382,462 21.48%

Holding current value

$7.97 Million

Previous $4.32 Million 2.92%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$8.04 - $11.87 $660,566 - $975,239	82,160 Added 21.48%	464,622 $4.2 Million
Q1 2024 May 10, 2024	BUY	$6.73 - $12.2 $243,565 - $441,530	36,191 Added 10.45%	382,462 $4.32 Million
Q4 2023 Feb 13, 2024	BUY	$5.52 - $8.03 $112,762 - $164,036	20,428 Added 6.27%	346,271 $2.76 Million
Q3 2023 Nov 13, 2023	BUY	$6.01 - $8.24 $188,371 - $258,266	31,343 Added 10.64%	325,843 $2.11 Million
Q2 2023 Aug 11, 2023	BUY	$3.68 - $6.9 $6,771 - $12,696	1,840 Added 0.63%	294,500 $1.82 Million
Q1 2023 May 12, 2023	SELL	$3.03 - $4.0 $52,664 - $69,524	-17,381 Reduced 5.61%	292,660 $1.13 Million
Q4 2022 Feb 13, 2023	BUY	$3.05 - $4.19 $50,416 - $69,260	16,530 Added 5.63%	310,041 $961,000
Q3 2022 Nov 14, 2022	SELL	$3.8 - $5.91 $31,935 - $49,667	-8,404 Reduced 2.78%	293,511 $1.18 Million
Q2 2022 Aug 12, 2022	BUY	$3.18 - $9.85 $80,762 - $250,160	25,397 Added 9.18%	301,915 $1.47 Million
Q1 2022 May 12, 2022	SELL	$7.45 - $11.59 $79,864 - $124,244	-10,720 Reduced 3.73%	276,518 $2.48 Million
Q4 2021 Feb 10, 2022	BUY	$10.99 - $17.54 $3.16 Million - $5.04 Million	287,238 New	287,238 $3.23 Million
Q3 2021 Nov 09, 2021	SELL	$16.7 - $23.11 $83,366 - $115,365	-4,992 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$21.71 - $25.66 $108,376 - $128,094	4,992 New	4,992 $110,000

Others Institutions Holding CNTA

# of Institutions

108

Shares Held

118M

Call Options Held

5.9K

Put Options Held

53K

View Full List

About Centessa Pharmaceuticals plc

Ticker CNTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,339,296
Market Cap $1.62B
Description
Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...

More about CNTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account